Vascular endothelial growth factor and its receptors

Cytokine and Growth Factor Reviews

Volumn 7, Issue 3, 1996, Pages 259-270

  Klagsbrun, Michael ^a   D'Amore, Patricia A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Vasculogenesis; VEGF; VEGF receptors; VPF

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LYMPHOKINE; PROTEIN TYROSINE KINASE; VASCULAR ENDOTHELIAL CELL GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CHEMISTRY; EMBRYOLOGY; ENDOTHELIUM CELL; EYE; FORECASTING; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RETINA NEOVASCULARIZATION; REVIEW; SEQUENCE HOMOLOGY; TUMOR VASCULARIZATION; VASCULARIZATION;

EID: 0030265393     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(96)00027-5     Document Type: Short Survey

References (136)

1. 1. Klagsbrun M, Folkman J. Angiogenesis. In Sporn MB, Roberts AB eds. Peptide Growth Factors and Their Receptors. New York, Springer, 1990, 549-586.
2. 2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987, 235, 442-447.
3. 3. Klagsbrun M. Vascular cell growth factors and the arterial wall. In Haber E ed. Molecular Cardiovascular Medicine. Scientific American Medicine. Scientific American Inc. New York, 1995, 63-68.
4. 4. Moses M, Klagsbrun M, Shing Y. The role of growth factors in vascular cell development and differentiation. Int Rev Cytology 1995, 161, 1-48.
5. 5. D'Amore PA, Klagsbrun M. Angiogenesis: factors and mechanisms. In Sirica AE, ed. The Pathobiology of Neoplasia. New York, Plenum Publishing Corporation, 1989, 513-531.
6. 6. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Ann Rev Physiol 1991, 53, 217-239.
7. 7. Klagsbrun M, Soker S. VEGF/VPF: the angiogenesis factor found? Curr Biol 1993, 3, 699-702.
8. 8. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 1992, 13, 18-32.
9. 9. Senger DR, Van De Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Canc Met Rev 1993, 12, 303-324.
10. 10. Ferrara N. Vascular endothelial growth factor. Trends Carciovasc Med 1993, 13, 244-250.
11. 11. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi B-Z. Vascular endothelial growth factor and its receptors. Progress in Growth Factor Res 1994, 5, 89-97.
12. 12. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995, 129, 895-898.
13. 13. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161, 851-855.
14. 14. Leung DW, Cachianes G. Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246, 1306-1309.
15. 15. Plouët J, Schilling J. Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 1989, 8, 3801-3806.
16. 16. Tischer E, Gospodarowicz D, Mitchell R, et al. Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989, 165, 1198-1206.
17. 17. Senger DR, Galli SJ. Dvorak AM, Peruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219, 983-985.
18. 18. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989, 246, 1309-1312.
19. 19. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989, 84, 1470-1478.
20. 20. Ijichi A, Sakuma S, Tofilom PJ. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia 1995, 14, 87-93.
21. 21. Dvorak HF, Sioussat TM, Brown LF, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 1991, 174, 1275-1278.
22. 22. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359, 845-848.
23. 23. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359, 843-845.
24. 24. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992, 3, 211-220.
25. 25. Freeman MR, Schneck FX, Gagnon ML, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 1995, 55, 4140-4145.
26. 26. Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992, 42, 1457-1461.
27. 27. Harada S. Rodan S, Rodan G. Expression and regulation of vascular endothelial growth factor in osteoblasts. Clin Ortho 1995, 313, 76-80.
28. 28. Iijima K, Yoshikawa N, Connolly DT, Nakamura H. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 1993, 44, 959-996.
29. 29. Tischer E. Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple proteins are encoded through alternative exon splicing. J Biol Chem 1991, 266, 11947-11954.
30. 30. Houck KA, Ferrara N, Winer J, Cachianes G. The vascular endothelial growth factor family: Identification of a 4th molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991, 5, 1806-1814.
31. 31. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992, 257, 26031-26037.
32. 32. Shima DT, Kuroki M, Deutsch U. Ng Y-S. Adamis AP, D'Amore PA. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 1996, 271, 3877-3883.
33. 33. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993, 4, 1317-1326.
34. 34. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992, 114, 521-532.
35. 35. Minchenko A, Bauer T, Salceda S, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994, 71, 374-379.
36. 36. Garrido G, Saule S, Gospodarowicz D. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors 1993, 8, 109-117.
37. 37. Shima DT, Gougos A, Miller JW, et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca faxicularis. Invest Ophthalmol Vis Sci 1996, 37, 1334-1347.
38. 38. Bacic M, Edwards NA, Merrill MJ. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 1995, 12, 11-15.
39. 39. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico M. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci 1991, 88, 9267-9271.
40. 40. Hauser S, Weich H. A heparin-binding form of placenta growth factor (P1GF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993, 9, 259-268.
41. 41. Cao Y, Chen H, Zhou L, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. J Biol Chem 1996, 271, 3154-3162.
42. 42. Barleon B, Hauser S, Schllman C, et al. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem 1994, 54, 56-66.
43. 43. Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci 1996, 93, 2576-2581.
44. 44. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15, 290-298.
45. 45. Lee J, Gray A, Yuan J, Louh S-M, Avraham H, Wood W. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci 1996, 93, 1988-1992.
46. 46. Keyt BA, Berleau LT, Nguyen HV, et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996, 271, 7788-7795.
47. 47. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993, 69, 508-517.
48. 48. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis. Biochem Biophys Res Commun 1992, 189, 824-831.
49. 49. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992, 267, 6093-6098.
50. 121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 1996, 271, 1-5.
51. 165 with soluble and cell associated flk-1 receptors. J Biol Chem 1994, 269, 12456-12461.
52. 52. Yoshida A, Anand-Apte B, Zetter B. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 1996, 13, 1-8.
53. 53. Grosskreutz CL, Anand-Apte B, Terman B, Quinn TP, D'Amore PA. Vascular endothelial growth factor (VEGF) is a chemoattractant for vascular smooth muscle cells (SMC). Invest Ophthalmol Vis Sci 1996, 37, 5470.
54. 54. Clauss M, Gerlach M, Gerlach H, et al. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990, 172, 1535-1545.
55. 55. Nicosia R, Nicosia S, Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 1994, 145, 1023-1029.
56. 56. Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tiss Res 1993, 274, 163-172.
57. 57. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis. A single intra-arterial bolus of vascular endothelial growth factor augments neovascularization in a rabbit ischemic hind limb model. J Clin Invest 1994, 93, 662-670.
58. 58. Takeshita S, Rossow ST, Kearney M, et al. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995, 147, 1649-1660.
59. 59. Ramakrishnan S, Oison T, Bautch V, Mahanraj D. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1 positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res 1996, 56, 1324-1330.
60. 60. Roberts WG, Palade GE. Increased micro vascular permeability and endothelial fenestration induced by vascular endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995, 108, 2369-2379.
61. 61. Dvorak AM, Kohn S, Morgan ES, Fox, P, Nagy JA, Dvorak HF. The vesiculo-vacuolar organelle (VVO) - a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. Leuk Biol 1996, 59, 100-115.
62. 62. Guerrin M, Moukadiri H, Chollet P, et al. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol 1995, 64, 385-394.
63. 63. Midy V, Plout J. Vasculotropin/vascular endothelial growth factor induced differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994, 199, 380-386.
64. 64. Enomoto T, Okamoto T, Sato J. Vascular endothelial growth factor induces the disorganization of actin stress fibers accompanied by protein tyrosine phosphorylation and morphological change in Balb/c3T3 cells. Biochem Biophys Res Commun 1994, 202, 1716-1723.
65. 65. Waltenberger J, Claesson-Welch L, Siegbahn A, Shibuya M, Heldin C-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994, 269, 26988-26995.
66. 66. Cohen T, Nahari D, Cerem L, Neufeld G, Levi B-Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996, 271, 736-741.
67. 67. Finkenzeller G, Marme D, Weich H, Hug H. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res 1992, 52, 4821-4823.
68. 68. Goldman CK, Kim J, Wong W-L, King V, Brock T, Gillespie GY. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993, 4, 121-133.
69. 69. Pertovaara L, Kaipainen A, Mustonen T, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and endothelial cells. J Biol Chem 1994, 269, 6271-6274.
70. 70. Tuder R, Flook B, Voelkel N. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. J Clin Invest 1995, 95, 1798-1807.
71. 71. Grugel S, Finkenzeller G, Weindel K, Barleon B, Marme D. Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cell. J Biol Chem 1995, 270, 25915-15919.
72. 72. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 1994, 267, H1948-H1954.
73. 73. Claffey K, Wilkison W, Spiegelman B, Vascular endothelial growth factor, regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992, 267, 16317-16322.
74. 74. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implication for tumor angiogenesis. Proc Natl Acad Sci USA 1995, 92, 768-772.
75. 75. Shima DT, Adamis AP, Yeo K-T, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med 1995, 1, 182-193.
76. 76. Pugh CW, Tan CC, Jones RW, Ratcliffe PJ. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene. Proc Natl Acad Sci USA 1991, 88, 10553-10557.
77. 77. Minchenko A, Salceda S, Bauer T, Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 1994, 40, 35-39.
78. 78. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor expression in endothelial cells: identification of a 5′ enhancer. Circ Res 1995, 77, 638-643.
79. 79. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995, 270, 13333-13340.
80. 80. Semenza GL, Roth PH, Fang H-M, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994, 269, 23757-23763.
81. 81. Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 1995, 370, 203-208.
82. 82. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996, 271, 2746-2753.
83. 83. Goldberg MA, Schneider TJ. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994, 269, 4355-4359.
84. 84. Dumont DJ, Fong, G-H, Puri MC, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dynamics 1995, 203, 80-92.
85. 85. Flamme I, Breier G, Risau W. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Devel Biol 1995, 169, 699-712.
86. 86. Kadokawa Y, Suemori H, Nakatsuji N. Cell lineage analyses of epithelia and blood vessels in chimeric mouse embryos by use of an embryonic stem cell line expressing the β-galactosidase gene. Cell Diff Devel 1990, 29, 187-194.
87. 87. Sariola H, Ekblom P, Lehtonen E, Saxen L. Differentiation and vascularization of the metanephric kidney on the chorioallantoic membrane. Devel Biol 1983, 24, 427-135.
88. 88. Carmeliet P, Ferriera V, Brier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380, 435-439.
89. 89. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380, 439-442.
90. 90. Flamme I. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Devel Biol 1995, 171, 399-414.
91. 91. Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA 1995, 92, 7657-7661.
92. 92. Shibuya M, Yamaguchi S, Yamane A, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990, 5, 519-524.
93. 93. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255, 989-991.
94. 94. Terman B, Carrion M, Kovacs E, Rasmussen B, Eddy R, Shows T. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991, 6, 1677-1683.
95. 95. Terman BI, Dougher-Verrnazen M, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992, 187, 1579-1586.
96. 96. Matthews W, Jordan C, Gavin M, Jenkins N, Copeland N, Lemischka I. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hemoatopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991, 88, 9026-9030.
97. 97. Guo D, Jia Q, Song H-Y, Warren R, Donner D. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J Biol Chem 1995, 270, 6729-6733.
98. 98. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995, 10, 135-147.
99. 99. Borg J-P, deLapeyriere O, Noguschi T, Rottapel R, Dubreuil P, Birnbaum D. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene 1994, 10, 973-984.
100. 100. Galland F, Karamysheva A, Pebusque M-J, et al. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 1993, 8, 1233-1240.
101. 101. Kaipainen A, Korhonen J, Pajusola K, et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Meet 1993, 178, 2077-2088.
102. 102. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1994, 92, 3566-3570.
103. 103. Pajusola K, Aprelikova O, Pelicci G. Weich H, Claesson-Welch L, Alitalo K. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 1994, 9, 3545-3555.
104. 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Cell 1995, 270, 11322-11326.
105. 165. J Biol Chem 1996, 271, 5761-5767.
106. 106. Breier G, Clauss M, Risau W. Coordinate expression of vascular endothelial growth factor-receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Devel Dynamics 1995, 204, 228-239.
107. 107. Millauer B, Wizigmann-Voos S, Schnüren H, et al. High affinity VEGF binding and developmental expression suggest FIk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72, 835-846.
108. 108. Peters KG, De Vries C, Williams LT. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993, 90, 8915-8919.
109. 109. Plate K, Breier G, Weich H, Mennel H, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms, Int J Cancer 1994, 59, 520-529.
110. 110. Yamane A, Seetharam L, Yamaguchi S, et al. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 1994, 9, 2683-2690.
111. 111. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island and vasculogenesis in FIk-1-deficient mice. Nature 1995, 376, 62-66.
112. 112. Fong G-H, Rossant J, Gertsenstein M, Breitman ML. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376, 66 68.
113. 113. Millauer B, Shawver LK, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994, 367, 576-579.
114. 114. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993, 91, 2235-2243.
115. 115. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Am J Pathol 1995, 146, 157-165.
116. 116. Rohovsky A, D'Amore PA. Growth factors and angiogenesis in wound healing. In Ziegler TR, Pierce GF, Herndon DN, eds. Growth Factors and Wound Healing: Basic Science and Potential Clinical Applications, NewYork, Springer, in press.
117. 117. Brown LF, Yeo K-T, Berse B, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exptl Med 1992, 9, 1375-1379.
118. 118. Bauters C, Asahara T, Zheng LP, et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 1995, 21, 314-325.
119. 119. Takeshita S, Pu LQ, Stein LA, et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in rabbit model of chronic limb ischemia. Circulation 1994, 90, II-228-II-234.
120. 120. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995, 15, 4738-4747.
121. 121. Miller JW, Adamis AP, Shima DT, et al. Vascular permeability factor/vascular endothelial cell growth factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994, 145, 574-584.
122. 122. Virdi PS, Hayreh SS. Ocular neovascularization with retinal vascular occlusion 1. Association with experimental retinal vein occlusion. Arch Ophthalmol 1982, 100, 331-341.
123. 123. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of VEGF prevents ocular neovascularization in a primate. Arch Ophthalmol 1996, 114, 66-71.
124. 124. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acaci Sci USA 1995, 92, 905-909.
125. 125. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King G, Smith LEH. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995, 92, 10457-10461.
126. 126. Chang-Ling T, Gock B, Stone J. Supplemental oxygen therapy. Basis for non-invasive treatment of retinopathy of prematurity. Invest Opthalmol Vis Sci 1995, 36, 1215-1230.
127. 127. Adamis AP, Miller JW, Bernal M-T, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118, 445-450.
128. 128. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Lab Sci 1994, 112, 1476-1482.
129. 129. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other ocular disorders. N Engl J Med 1994, 331, 1480-1487.
130. 130. Anan K, Morisaki T, Katano M, et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 1996, 119, 333-339.
131. 131. Kondo S, Asano M, Suzuki H. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 1993, 194, 1234-1241.
132. 132. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothetial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993, 362, 841-844.
133. 133. Warren RS, Yuan H, Matli MR, Gillett N, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995, 95, 1789-1797.
134. 134. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med 1973, 138, 745-753.
135. 135. Claffey KP, Brown LF, del Aguila LF, et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996, 56, 172-196.
136. 136. Jakeman LB, Armanini M, Phillips HS, Ferrara N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 1993, 133, 848-859.